These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31494952)

  • 1. Clinical implications of LDH isoenzymes in hemolysis and continuous-flow left ventricular assist device-induced thrombosis.
    Gordon JS; Wood CT; Luc JGY; Watson RA; Maynes EJ; Choi JH; Morris RJ; Massey HT; Throckmorton AL; Tchantchaleishvili V
    Artif Organs; 2020 Mar; 44(3):231-238. PubMed ID: 31494952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminatory performance of positive urine hemoglobin for detection of significant hemolysis in patients with continuous-flow left ventricular assist devices.
    Gavalas MV; Breskin A; Yuzefpolskaya M; Eisenberger A; Castagna F; Demmer RT; Flannery M; Garan AR; Takeda K; Takayama H; Naka Y; Topkara VK; Colombo PC
    J Heart Lung Transplant; 2017 Jan; 36(1):59-63. PubMed ID: 27773451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic prediction of left ventricular assist device pump thrombosis based on lactate dehydrogenase trends.
    Hurst TE; Xanthopoulos A; Ehrlinger J; Rajeswaran J; Pande A; Thuita L; Smedira NG; Moazami N; Blackstone EH; Starling RC
    ESC Heart Fail; 2019 Oct; 6(5):1005-1014. PubMed ID: 31318170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early intervention for lactate dehydrogenase elevation improves clinical outcomes in patients with the HeartMate II left ventricular assist device: Insights from the PREVENT study.
    Thenappan T; Stulak JM; Agarwal R; Maltais S; Shah P; Eckman P; Emani S; Katz JN; Gregoric I; Keebler ME; Uriel N; Adler E; Chuang J; Farrar DJ; Sundareswaran KS; John R
    J Heart Lung Transplant; 2018 Jan; 37(1):25-32. PubMed ID: 29153636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
    Cowger JA; Romano MA; Shah P; Shah N; Mehta V; Haft JW; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):35-43. PubMed ID: 24418732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and In Vitro Evidence That Subclinical Hemolysis Contributes to LVAD Thrombosis.
    Bartoli CR; Zhang D; Kang J; Hennessy-Strahs S; Restle D; Howard J; Redline G; Bermudez C; Atluri P; Acker MA
    Ann Thorac Surg; 2018 Mar; 105(3):807-814. PubMed ID: 28942075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of echocardiography in patients with intravascular hemolysis due to suspected continuous-flow LVAD thrombosis.
    Fine NM; Topilsky Y; Oh JK; Hasin T; Kushwaha SS; Daly RC; Joyce LD; Stulak JM; Pereira NL; Boilson BA; Clavell AL; Edwards BS; Park SJ
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1129-40. PubMed ID: 24094831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices.
    Tellor BR; Smith JR; Prasad SM; Joseph SM; Silvestry SC
    J Heart Lung Transplant; 2014 Jan; 33(1):94-101. PubMed ID: 24418735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
    Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De Ritis-adjusted AST provides comparable efficacy to lactate dehydrogenase as a biomarker for detection of LVAD hemolysis or thrombosis.
    Schettle S; Rosenbaum A; Goodman D; Stulak J
    Artif Organs; 2022 Jul; 46(7):1425-1428. PubMed ID: 35318681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Center Experience With HeartMate II Left Ventricular Assist Device Explantation.
    Tchantchaleishvili V; Cheyne C; Sherazi S; Melvin AL; Hallinan W; Chen L; Todd Massey H
    Artif Organs; 2016 Dec; 40(12):1145-1149. PubMed ID: 27076358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Courses of HeartMate II Left Ventricular Assist Device Thrombosis.
    Kittipibul V; Xanthopoulos A; Hurst TE; Fukamachi K; Blackstone EH; Soltesz E; Starling RC
    ASAIO J; 2020 Feb; 66(2):153-159. PubMed ID: 30688690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexpected abrupt increase in left ventricular assist device thrombosis.
    Starling RC; Moazami N; Silvestry SC; Ewald G; Rogers JG; Milano CA; Rame JE; Acker MA; Blackstone EH; Ehrlinger J; Thuita L; Mountis MM; Soltesz EG; Lytle BW; Smedira NG
    N Engl J Med; 2014 Jan; 370(1):33-40. PubMed ID: 24283197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon.
    Uriel N; Han J; Morrison KA; Nahumi N; Yuzefpolskaya M; Garan AR; Duong J; Colombo PC; Takayama H; Thomas S; Naka Y; Jorde UP
    J Heart Lung Transplant; 2014 Jan; 33(1):51-9. PubMed ID: 24290832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte aging as a mechanism of anemia and a biomarker of device thrombosis in continuous-flow left ventricular assist devices.
    Taimeh Z; Koene RJ; Furne J; Singal A; Eckman PM; Levitt MD; Pritzker MR
    J Heart Lung Transplant; 2017 Jun; 36(6):625-632. PubMed ID: 28396088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of hemolysis and device thrombosis with lactate dehydrogenase during left ventricular assist device support.
    Shah P; Mehta VM; Cowger JA; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):102-4. PubMed ID: 23968811
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemolysis in left ventricular assist device: a retrospective analysis of outcomes.
    Ravichandran AK; Parker J; Novak E; Joseph SM; Schilling JD; Ewald GA; Silvestry S
    J Heart Lung Transplant; 2014 Jan; 33(1):44-50. PubMed ID: 24418733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolysis, pump thrombus, and neurologic events in continuous-flow left ventricular assist device recipients.
    Whitson BA; Eckman P; Kamdar F; Lacey A; Shumway SJ; Liao KK; John R
    Ann Thorac Surg; 2014 Jun; 97(6):2097-103. PubMed ID: 24775803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematologic markers better predict left ventricular assist device thrombosis than echocardiographic or pump parameters.
    Bartoli CR; Ghotra AS; Pachika AR; Birks EJ; McCants KC
    Thorac Cardiovasc Surg; 2014 Aug; 62(5):414-8. PubMed ID: 24995532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel thrombosis risk index as predictor of left ventricular assist device thrombosis.
    Trivedi JR; Sobieski MA; Schwartz S; Williams ML; Slaughter MS
    ASAIO J; 2013; 59(4):380-3. PubMed ID: 23820276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.